Miles W. Carroll
0000-0002-7026-7187
Publication & Citation Trends
Most Cited Works
Publications
356 total
The pharmacokinetics, bio-distribution and therapeutic efficacy of a trimeric nanobody against SARS-CoV-2 in the Syrian golden hamster COVID-19 model
Cited by 0
Semantic Scholar
Hamsters immunized with formalin-inactivated SARS-CoV-2 develop accelerated lung histopathological lesions and Th2-biased response following infection
Cited by 0
Semantic Scholar
Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents OA
Cited by 6
Semantic Scholar
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses PDF
Cited by 1,009
OpenAlex
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera PDF
Cited by 1,144
OpenAlex
Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum PDF
Cited by 747
OpenAlex
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera PDF
Cited by 529
OpenAlex
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PDF
Cited by 2,608
OpenAlex
Animal models for COVID-19 PDF
Cited by 869
OpenAlex
Research Topics
SARS-CoV-2 and COVID-19 Research
(149)
Viral Infections and Outbreaks Research
(86)
COVID-19 Clinical Research Studies
(83)
Viral Infections and Vectors
(66)
Immunotherapy and Immune Responses
(40)
Frequent Co-Authors
Affiliations
Agency for Science, Technology and Research
National Health Service
University of Iowa
The Pirbright Institute
Google (United States)